Category Industry Updates

Paradromics Achieves Real-Time Speech with Connexus Brain-Computer Interface

Paradromics Connexus BCI Enables First Participant to Communicate in Real Time Using Neural Signals Paradromics Inc., a neurotechnology company developing a high-data-rate brain-computer interface (BCI) platform aimed at restoring and enhancing human capabilities, has announced a major clinical milestone involving…

Read MoreParadromics Achieves Real-Time Speech with Connexus Brain-Computer Interface

One Biosciences Secures €3.3M France 2030 Funding for Breast Cancer Diagnostic

One Biosciences and Institut Curie Secure €3.3 Million France 2030 Funding to Advance Single-Cell Diagnostics for Triple-Negative Breast Cancer One Biosciences, a techbio company spun out of Institut Curie and focused on developing clinical-grade single-cell tumor profiling technologies, and Institut…

Read MoreOne Biosciences Secures €3.3M France 2030 Funding for Breast Cancer Diagnostic

Mobile Heartbeat Expands Clinical Communication Network with Private 5G Support

Mobile Heartbeat Expands Banyan Platform with Private 5G Support for Healthcare Communications Mobile Heartbeat, a provider of clinical communication and collaboration solutions, has announced that its Banyan platform now supports private 5G networks, expanding the connectivity options available to healthcare…

Read MoreMobile Heartbeat Expands Clinical Communication Network with Private 5G Support

BioLab Holdings Expands Placental Membrane Portfolio with New Hydrated Amnion Membrane

BioLab Holdings Expands Placental Membrane Portfolio With New Membrane Wrap Amniotic Hydro BioLab Holdings, Inc., a Phoenix-based medical technology company focused on tissue restoration, has expanded its portfolio of placental membrane products with the addition of Membrane Wrap™ Amniotic Hydro.…

Read MoreBioLab Holdings Expands Placental Membrane Portfolio with New Hydrated Amnion Membrane

TwoStep Therapeutics Raises $62.5M Series A and Secures FDA IND Clearance for First-in-Class Peptide-Drug Conjugate

TwoStep Therapeutics Secures $62.5 Million Series A and FDA Clearance for TS-104 Phase 1 Trial TwoStep Therapeutics, a biotechnology company developing multi-specific targeted therapies for solid tumors, has announced two significant milestones that mark the company’s transition into clinical development.…

Read MoreTwoStep Therapeutics Raises $62.5M Series A and Secures FDA IND Clearance for First-in-Class Peptide-Drug Conjugate

Foot Levelers Announces First Chiropractic PracticeXcelerator® Continuing Education and Headquarters Tour

Foot Levelers Announces First-Ever Founder’s Edition PracticeXcelerator Workshop for Chiropractors Foot Levelers, a global leader in custom stabilizing orthotics, has announced its first-ever Founder’s Edition event, an expanded educational and professional development program designed specifically for chiropractors. The two-day event…

Read MoreFoot Levelers Announces First Chiropractic PracticeXcelerator® Continuing Education and Headquarters Tour

RMA New Jersey Welcomes Reproductive Endocrinologist Dr. Blake Vessa to Expand Fertility Care

IVI RMA North America Welcomes Reproductive Endocrinologist Dr. Blake Vessa to RMA New Jersey IVI RMA North America, a leader in fertility care and assisted reproductive medicine, has announced the appointment of Dr. Blake Vessa, a reproductive endocrinologist and infertility…

Read MoreRMA New Jersey Welcomes Reproductive Endocrinologist Dr. Blake Vessa to Expand Fertility Care

Encoded Therapeutics Presents Updated ETX101 Data from POLARIS Trials in Dravet Syndrome

Encoded Therapeutics Reports Durable Seizure Reduction and Neurodevelopmental Gains With ETX101 in Dravet Syndrome Encoded Therapeutics, Inc., a clinical-stage biotechnology company focused on developing precision genetic medicines for severe neurological disorders, has announced new Phase 1/2 clinical data for ETX101,…

Read MoreEncoded Therapeutics Presents Updated ETX101 Data from POLARIS Trials in Dravet Syndrome